Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Todd M. Scheub, Executive Vice President at Finward Bancorp (NASDAQ:FNWD), completed a purchase of company common stock on June 30, 2026. The transaction, valued at $1,402, was executed through the firm's Dividend Reinvestment Plan, reflecting continued insider accumulation within the banking sector. This acquisition brings Scheub's total indirect …
Finward Bancorp director Amy Wong Han has increased her direct ownership in the regional bank through a dividend reinvestment transaction. The acquisition aligns with the company's long-standing commitment to shareholder returns and its recent declaration of a quarterly dividend payment. The transaction provides insight into executive-level confide…
Carter Ryan Stuart, Executive Vice President of Gladstone Commercial Corp (NASDAQ: GOOD), completed a share purchase on July 1, 2026, acquiring 100 shares at $12.26 each. The transaction, valued at $1,226, was executed under a 10b5-1 plan, bringing his direct holdings to 4,700 shares. This activity occurs as the stock trades near the purchase price…
Horizon Kinetics Asset Management LLC, already a significant 10% stakeholder in Texas Pacific Land Corp (NYSE:TPL), executed a purchase of 1 share on June 30, 2026, valued at approximately $435.74 per share. This transaction, filed via Form 4 on July 1, 2026, brings the firm's direct holdings to 3,393,563 shares. The acquisition occurs amidst a per…
Charles D. Way, a director at World Acceptance Corp. (NASDAQ:WRLD), executed a significant equity transaction in late June 2026, disposing of 833 shares valued at $187,425. This sale coincides with the company's recent release of its fourth-quarter fiscal 2026 financial results, which presented a mixed picture for investors. While World Acceptance …
Finward Bancorp director Anthony Puntillo recently increased his direct holdings in the company by acquiring 6.5204 shares through the firm's Dividend Reinvestment Plan. The transaction, valued at $233, occurred on June 30, 2026, bringing his direct share count to 2,321.0172 shares. This move coincides with the company's announcement of a quarterly…
Benjamin J. Bochnowski, who serves as the President and Chief Executive Officer of Finward Bancorp (NASDAQ: FNWD), recently acquired a small number of shares in the company. The transaction, executed on June 30, 2026, was facilitated through the firm's Profit Sharing and Dividend Reinvestment Plans. This activity coincides with the company's announ…
Cavco Industries, Inc. (NASDAQ: CVCO) Executive Vice President Allison Aden has completed a significant stock transaction, selling 1,473 shares of the company's common stock. The sale, totaling $920,625, was executed at a price of $625.00 per share on June 25, 2026. This activity occurs within the context of Cavco's recent financial reporting for t…
Horizon Kinetics Asset Management LLC, a major stakeholder in RENN Fund, Inc., executed a purchase of the issuer's common equity on June 30, 2026. The transaction adds to the firm's existing stake, which now totals 928,128 shares, reinforcing its status as a significant 10% owner. The acquisition occurs as RENN Fund shares trade near $3.09, marking…
Vicor Corp. Chairman and CEO Patrizio Vinciarelli sold 20,000 shares of the company's common stock on June 30, 2026, generating approximately $7.5 million. The transaction was conducted under a Rule 10b5-1 trading plan adopted in February 2026, a structure designed to facilitate predetermined stock sales independent of subsequent market movements o…
Coastlands Capital LP, a ten percent owner of Adial Pharmaceuticals, increased its indirect holdings in the micro-cap pharmaceutical company on June 29, 2026. The acquisition comes as Adial Pharmaceuticals works to expand its product pipeline through strategic financing and patent filings for investigational drugs.
Maimon Shalom Arik, Chief Executive Officer of Cuentas Inc. (NASDAQ:CUEN), has executed open market purchases of the company's common stock. The transactions, totaling $5,386, occurred between June 22 and June 30, 2026. These acquisitions took place while the stock was trading at its 52-week high of $0.36, following a substantial 359,400% return ov…
Cuentas Inc. CEO Shalom Arik Maimon recently executed mixed trading activity, purchasing 15,000 shares while disposing of 100 shares. This occurs as the stock reaches a 52-week high of $0.36 and the company reports a substantial improvement in its annual net loss for 2025, driven by debt restructuring and joint venture contributions.
Cuentas Inc. (NASDAQ:CUEN) Chief Executive Officer Maimon Shalom Arik has executed a series of open market transactions to increase his direct ownership in the company. The purchases occurred as the stock approached its 52-week high, signaling executive confidence during a period of reported financial improvement. Concurrently, the company disclose…
Daniel Timothy Hudson, a director at Hallador Energy Co. (NASDAQ: HNRG), recently acquired 10,000 shares of the company's common stock on June 29, 2026. This transaction, valued at $169,400, brings his direct ownership to 15,000 shares. The purchase occurred as the company navigates a disappointing first quarter of 2026, with the stock currently tr…
OAS Energy LLC, acting through its Chief Accounting and Information Officer, executed a series of common stock purchases in Cuentas Inc. (NASDAQ:CUEN) on June 30, 2026. The transactions totaled $2,317, with shares acquired at prices ranging from $0.3262 to $0.3595. This activity increased the entity's direct ownership to 100,621 shares. The purchas…
Daniel J. Lippis, Corporate Vice President of Transcatheter Aortic Valve Replacement at Edwards Lifesciences Corp, executed a series of stock transactions on June 30, 2026. The executive sold 619 shares valued at approximately $56,576 under a pre-established trading plan, while simultaneously acquiring an equal number of shares through option exerc…
Universal Technical Institute Inc. (NASDAQ: UTI) CEO Jerome Alan Grant executed a significant divestment of 94,500 shares on June 29, 2026, totaling approximately $3.91 million. The transaction was disclosed for personal tax planning purposes, occurring as the stock trades near its perceived fair value. This move follows recent earnings beats and a…
Aoife Brennan, President and Chief Executive Officer of Climb Bio, Inc. (NASDAQ:CLYM), executed a sale of 30,902 shares of the company’s common stock on June 29, 2026, generating total proceeds of $406,979. The transaction was carried out under a pre-arranged 10b5-1 trading plan adopted on August 30, 2024, specifically to satisfy tax withholding re…
Windacre Partnership LLC, a major 10% shareholder in Perimeter Solutions, Inc. (NASDAQ:PRM), executed a substantial divestiture of its holdings, offloading approximately $195.6 million worth of ordinary shares between June 26 and June 30, 2026. This transaction follows a period of significant price appreciation for PRM, which has seen a 156% gain o…
Sardar Biglari's affiliated entity, Lion Fund II, L.P., executed a series of transactions disposing of approximately $3.7 million in El Pollo Loco Holdings, Inc. stock between June 26 and June 30, 2026. The sales occurred at weighted average prices ranging from $16.58 to $16.91 per share, leaving the fund with a remaining stake of 3,777,400 shares.…
Galectin Therapeutics director Harold H. Shlevin has completed the sale of 30,000 common shares, netting approximately $150,890. The transactions, executed under a Rule 10b5-1 plan, involved the disposal of shares acquired through option exercises. This activity coincides with significant regulatory and clinical developments for the company's lead …
Joan M. Herman, Executive Vice President of Operations and a director at Paysign, Inc. (NASDAQ:PAYS), executed a significant divestment of company equity on June 26, 2026. The transaction involved the sale of 100,000 shares of common stock, generating total proceeds of $801,140. This sale was facilitated through a Rule 10b5-1 trading plan, which He…
Jamil Khurram, Chief Medical Officer at Galectin Therapeutics Inc. (NASDAQ: GALT), executed a series of stock transactions between June 26 and June 29, 2026, under a Rule 10b5-1 trading plan. The executive sold 52,037 shares for $262,083 after acquiring the same number of shares through option exercises valued at $129,481. Following these transacti…
Omada Health, Inc. (NASDAQ: OMDA) Chief Accounting Officer Craig Gracey recently completed a series of stock transactions valued at $85,423, selling a total of 4,167 shares between June 26 and June 29, 2026. The sales were executed under a pre-established 10b5-1 trading plan adopted in March 2026. These transactions occurred during a period of sign…
